Literature DB >> 35398047

Five-Year Cumulative Incidence of Axillary Web Syndrome and Comparison in Upper Extremity Movement, Function, Pain, and Lymphedema in Survivors of Breast Cancer With and Without Axillary Web Syndrome.

Linda Koehler1, Amanda Day2, David Hunter3, Anne Blaes4, Tufia Haddad5, Ryan Shanley6.   

Abstract

OBJECTIVE: To determine the cumulative incidence and natural history of axillary web syndrome (AWS) and its related postoperative risk for physical impairments in a cohort of women followed for 5 years post breast cancer surgery.
DESIGN: Prospective, longitudinal study.
SETTING: Academic health center. PARTICIPANTS: Women (N=36) with and without AWS after breast cancer surgery with sentinel node biopsy or axillary lymph node dissection.
INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Participants were assessed for AWS, shoulder goniometric flexion and abduction range of motion, function (Disability of the Arm, Shoulder, and Hand), lymphedema (bioimpedance spectroscopy, girth measures, tissue dielectric constant), and pain (visual analog scale) at 2, 4, 12, and 78 weeks and 5 years after breast cancer surgery. Analysis of variance compared range of motion, function, lymphedema, and pain in women identified with AWS with those without AWS across visits. Univariate logistic regression assessed if AWS was a risk factor for physical impairment at 5 years.
RESULTS: The cumulative incidence of AWS was 57%. Fifty percent (14/28) of the women who completed all study visits had signs of AWS at 5 years. Abduction active range of motion was significantly lower in women with AWS at 2 and 4 weeks post surgery. AWS was identified as a risk factor for reduced shoulder motion at 5 years. Regardless of AWS, 75% of the women experienced 1 or more upper extremity physical impairments at 5 years, which is an increase from 66% at 78 weeks in the same cohort.
CONCLUSIONS: AWS is associated with reduced shoulder range of motion in the early postoperative time period, can persist for 5 years after breast cancer surgery, and increases the risk of long-term reduced shoulder range of motion. Long-term physical issues are apparent after breast cancer surgery regardless of AWS.
Copyright © 2022 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast neoplasms; Incidence; Lymphedema; Rehabilitation

Mesh:

Year:  2022        PMID: 35398047      PMCID: PMC9452471          DOI: 10.1016/j.apmr.2022.03.007

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   4.060


  48 in total

1.  Movement, Function, Pain, and Postoperative Edema in Axillary Web Syndrome.

Authors:  Linda A Koehler; Anne H Blaes; Tuffia C Haddad; David W Hunter; Alan T Hirsch; Paula M Ludewig
Journal:  Phys Ther       Date:  2015-05-14

Review 2.  Shoulder and arm morbidity in sentinel node-negative breast cancer patients: a systematic review.

Authors:  Hanne Verbelen; Nick Gebruers; Fau-Mei Eeckhout; Kim Verlinden; Wiebren Tjalma
Journal:  Breast Cancer Res Treat       Date:  2014-02-05       Impact factor: 4.872

3.  Long-term morbidity following axillary dissection in breast cancer patients--clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors.

Authors:  T Kuehn; W Klauss; M Darsow; S Regele; F Flock; C Maiterth; R Dahlbender; I Wendt; R Kreienberg
Journal:  Breast Cancer Res Treat       Date:  2000-12       Impact factor: 4.872

4.  Incidence and predictors of axillary web syndrome and its association with lymphedema in women following breast cancer treatment: a retrospective study.

Authors:  Kathryn Ryans; Claire C Davies; Gizela Gaw; Caroline Lambe; Morgan Henninge; Lisa VanHoose
Journal:  Support Care Cancer       Date:  2020-04-08       Impact factor: 3.603

5.  Characterizing axillary web syndrome: ultrasonographic efficacy.

Authors:  L A Koehler; D W Hunter; T C Haddad; A H Blaes; A T Hirsch; P M Ludewig
Journal:  Lymphology       Date:  2014-12       Impact factor: 1.286

6.  Preoperative assessment enables the early diagnosis and successful treatment of lymphedema.

Authors:  Nicole L Stout Gergich; Lucinda A Pfalzer; Charles McGarvey; Barbara Springer; Lynn H Gerber; Peter Soballe
Journal:  Cancer       Date:  2008-06-15       Impact factor: 6.860

Review 7.  Patient-reported upper extremity outcome measures used in breast cancer survivors: a systematic review.

Authors:  Shana Harrington; Lori A Michener; Tiffany Kendig; Susan Miale; Steven Z George
Journal:  Arch Phys Med Rehabil       Date:  2013-08-06       Impact factor: 3.966

8.  Modern treatment of lymphoedema. I. Complex physical therapy: the first 200 Australian limbs.

Authors:  J R Casley-Smith; J R Casley-Smith
Journal:  Australas J Dermatol       Date:  1992       Impact factor: 2.875

9.  Tissue Dielectric Constant Measures in Women With and Without Clinical Trunk Lymphedema Following Breast Cancer Surgery: A 78-Week Longitudinal Study.

Authors:  Linda A Koehler; Harvey N Mayrovitz
Journal:  Phys Ther       Date:  2020-08-12

10.  Predictors of Altered Upper Extremity Function During the First Year After Breast Cancer Treatment.

Authors:  Betty Smoot; Steven M Paul; Bradley E Aouizerat; Laura Dunn; Charles Elboim; Brian Schmidt; Deborah Hamolsky; Jon D Levine; Gary Abrams; Judy Mastick; Kimberly Topp; Christine Miaskowski
Journal:  Am J Phys Med Rehabil       Date:  2016-09       Impact factor: 2.159

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.